You're contacting media contact of this press release
Title: GLP-1 Planet Names CoreAge Rx Top Provider Out of 78 Compared, Awarding 9.6-10 Rating and Recognizing $99/Month Flat Pricing for Weight Management Care
Portland, OR 97201, United States, 18th Feb 2026 - An independent GLP-1 comparison platform, GLP1Planet.com, has awarded CoreAge Rx a rating of 9.6 out of 10 and identified it as its recommended provider after reviewing 78 GLP-1 medication services. According to GLP-1 Planet’s published review, the evaluation focused on key criteria including pricing transparency, service quality, medication access, and patient support. Based on these findings, CoreAge Rx was recognized as offering one of the most competitive and transparent pricing models in the GLP-1 market, with a flat monthly price of $99.GLP-1 Planet reported that CoreAge Rx’s pricing model includes virtual doctor consultation, GLP-1 medication, ongoing medical support and monitoring, and delivery directly to the patient’s door. The platform noted that the $99 monthly price remains consistent regardless of dose, and it does not include hidden fees or surprise charges. This pricing structure, combined with service quality and access to licensed healthcare providers, contributed to CoreAge Rx receiving the platform’s highest overall rating among the providers reviewed.According to GLP-1 Planet’s analysis, CoreAge Rx offers access to GLP-1 medications including semaglutide and tirzepatide through its telemedicine platform. The review stated that CoreAge Rx provides consultations with licensed healthcare providers who evaluate patients through an online medical assessment process before determining whether GLP-1 medication is appropriate. If prescribed, the medication is shipped directly to the patient with ongoing medical support.GLP-1 Planet also reported that CoreAge Rx operates with HIPAA compliance and employs licensed physicians to oversee care. The platform highlighted that CoreAge Rx provides multiple support c...
This press release is issued by King Newswire